Cargando…
Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives
INTRODUCTION: In China, Traditional Chinese Medicine (TCM) is an integral part of the health system in parallel with Western medicine (WM). However, pharmacists’ duty of care at this interface has not been fully explored. This qualitative study aimed to explore key stakeholders’ perceptions about th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102831/ https://www.ncbi.nlm.nih.gov/pubmed/32288883 http://dx.doi.org/10.1016/j.eujim.2020.101063 |
_version_ | 1783511921038721024 |
---|---|
author | Yao, Dongning Hu, Hao Harnett, Joanna E. Ung, Carolina Oi Lam |
author_facet | Yao, Dongning Hu, Hao Harnett, Joanna E. Ung, Carolina Oi Lam |
author_sort | Yao, Dongning |
collection | PubMed |
description | INTRODUCTION: In China, Traditional Chinese Medicine (TCM) is an integral part of the health system in parallel with Western medicine (WM). However, pharmacists’ duty of care at this interface has not been fully explored. This qualitative study aimed to explore key stakeholders’ perceptions about the challenges and enablers to pharmacists’ adopting a professional role in patient care associated with the concurrent use of herbal medicines (HMs). METHODS: Participants were recruited from the expert pool of the National Research Center for Licensed Pharmacist Development using purposive sampling and snowballing. Participants targeted included government, academics and practicing pharmacists. An interview guide was developed following a literature review and face-to-face, audiotaped interviews conducted with key stakeholders. RESULTS: Fourteen semi-structured interviews with both practicing pharmacists and key stakeholder representatives were conducted in China in 2017. Thematic analysis identified 6 main themes which focused on how TCM was integrated with WM in China. Participants agreed that pharmacists should at least assume a role in drug safety associated with concurrent use of TCM and WM. However, barriers were identified within the government, education, pharmacy, pharmacist and research sectors, indicating a lack of coordinated strategies to improve this area of healthcare. A lack of clarity in defining the pharmacists’ role in this area and a disconnect between current regulatory standards and education/training system were the prominent themes. Participants looked towards the government to facilitate actions in the development of policies that support pharmacy practice and practice guidelines, and the review of competency standards, and registration criteria as being the most important enablers. CONCLUSION: Guiding principles that outline standards for pharmacy practice regarding HMs in an integrated healthcare system are considered a priority, requiring a joint effort from the government, professional organizations and universities. |
format | Online Article Text |
id | pubmed-7102831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71028312020-03-31 Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives Yao, Dongning Hu, Hao Harnett, Joanna E. Ung, Carolina Oi Lam Eur J Integr Med Article INTRODUCTION: In China, Traditional Chinese Medicine (TCM) is an integral part of the health system in parallel with Western medicine (WM). However, pharmacists’ duty of care at this interface has not been fully explored. This qualitative study aimed to explore key stakeholders’ perceptions about the challenges and enablers to pharmacists’ adopting a professional role in patient care associated with the concurrent use of herbal medicines (HMs). METHODS: Participants were recruited from the expert pool of the National Research Center for Licensed Pharmacist Development using purposive sampling and snowballing. Participants targeted included government, academics and practicing pharmacists. An interview guide was developed following a literature review and face-to-face, audiotaped interviews conducted with key stakeholders. RESULTS: Fourteen semi-structured interviews with both practicing pharmacists and key stakeholder representatives were conducted in China in 2017. Thematic analysis identified 6 main themes which focused on how TCM was integrated with WM in China. Participants agreed that pharmacists should at least assume a role in drug safety associated with concurrent use of TCM and WM. However, barriers were identified within the government, education, pharmacy, pharmacist and research sectors, indicating a lack of coordinated strategies to improve this area of healthcare. A lack of clarity in defining the pharmacists’ role in this area and a disconnect between current regulatory standards and education/training system were the prominent themes. Participants looked towards the government to facilitate actions in the development of policies that support pharmacy practice and practice guidelines, and the review of competency standards, and registration criteria as being the most important enablers. CONCLUSION: Guiding principles that outline standards for pharmacy practice regarding HMs in an integrated healthcare system are considered a priority, requiring a joint effort from the government, professional organizations and universities. Elsevier GmbH. 2020-02 2020-02-05 /pmc/articles/PMC7102831/ /pubmed/32288883 http://dx.doi.org/10.1016/j.eujim.2020.101063 Text en © 2020 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yao, Dongning Hu, Hao Harnett, Joanna E. Ung, Carolina Oi Lam Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title | Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title_full | Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title_fullStr | Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title_full_unstemmed | Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title_short | Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives |
title_sort | integrating traditional chinese medicines into professional community pharmacy practice in china – key stakeholder perspectives |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102831/ https://www.ncbi.nlm.nih.gov/pubmed/32288883 http://dx.doi.org/10.1016/j.eujim.2020.101063 |
work_keys_str_mv | AT yaodongning integratingtraditionalchinesemedicinesintoprofessionalcommunitypharmacypracticeinchinakeystakeholderperspectives AT huhao integratingtraditionalchinesemedicinesintoprofessionalcommunitypharmacypracticeinchinakeystakeholderperspectives AT harnettjoannae integratingtraditionalchinesemedicinesintoprofessionalcommunitypharmacypracticeinchinakeystakeholderperspectives AT ungcarolinaoilam integratingtraditionalchinesemedicinesintoprofessionalcommunitypharmacypracticeinchinakeystakeholderperspectives |